According to VectivBio's latest financial reports the company's current earnings (TTM) are -$93.63 M. In 2022 the company made an earning of -$93.63 M a decrease over its 2021 earnings that were of -$86.95 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2022 | -$93.63 M | 7.69% |
2021 | -$86.95 M | 45.05% |
2020 | -$59.95 M | 155.28% |
2019 | -$23.49 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Organovo ONVO | -$19.09 M | -79.62% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | -$73.07 M | -21.97% | ๐ฌ๐ง UK |
Novavax NVAX | -$0.53 B | 464.59% | ๐บ๐ธ USA |
Novocure
NVCR | -$0.19 B | 101.24% | Jersey |